Biopharmaceutical industry policies aim to increase access to clinical trial data

Today, astudy published in the British Medical Journal (BMJ) sought to audit industry clinical trial disclosure and data sharing policies. The study, entitledPharmaceutical companies ’ policies on access to trial data, results, and methods: audit study, and authored by affiliates of the AllTrials organization, looked at company policies with regard to registration, methods and summary results, CSRS and individual patient data.

Source: The Catalyst - July 27, 2017 Category: Pharmaceuticals Authors: Olivia Shopshear Tags: Clinical Trials Source Type: news